English | Español
Patient Daily | Dec 16, 2025

American Lung Association offers free resources for quitting all nicotine products
Patient Daily | Dec 16, 2025

Pharmaceutical firms urge FDA reform on inspection timing linked to drug approvals
Patient Daily | Dec 16, 2025

Penn Medicine launches $25M remote study using smartphones for heart disease prevention
Patient Daily | Dec 15, 2025

Five clinical breakthroughs define biopharma progress amid challenges in 2025
Patient Daily | Dec 15, 2025

Ohio State explores new treatments for drug-resistant epilepsy
Patient Daily | Dec 15, 2025

FDA faces challenges with drugs failing key clinical trial benchmarks
Patient Daily | Dec 15, 2025

FARE medical director to join FDA-Duke Margolis panel on epinephrine access
Patient Daily | Dec 12, 2025

Ohio State researchers seek improved methods for treating depression

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Regulatory
Patient Daily | Apr 9, 2026

Reason Foundation commentator on vaccine liability: 'Exposing vaccine makers to the machinations of trial lawyers will stymie the development of innovative vaccines'
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'